Intracranial pressure (ICP) monitoring devices are used to monitor the pressure inside the skull and brain. These devices help in diagnosing and treating conditions associated with elevated ICP such as traumatic brain injuries (TBIs), hemorrhagic and ischemic strokes, and other brain tumors. ICP monitoring devices provide valuable information about cerebral blood flow and assist doctors in adjusting treatments to maintain appropriate cerebral perfusion pressure. Key players operating in the intracranial pressure monitoring devices market are Codman & Shurtleff Incorporated, Sophysa, Gaeltec Devices Limited, Integra Lifesciences Co., Raumedic AG, VITTAMED, Orsan Medical Technologies, Haiying Medical, and other.

The Global intracranial pressure monitoring devices market is estimated to be valued at US$ 1.68 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the intracranial pressure monitoring devices are Codman & Shurtleff Incorporated, Sophysa, Gaeltec Devices Limited, Integra Lifesciences Co., Raumedic AG, VITTAMED, Orsan Medical Technologies, Haiying Medical, and other. The rising incidence of traumatic brain injuries due to road accidents and falls has resulted in increased demand for intracranial pressure monitoring devices. According to Brain Injury Association, over 5.3 million Americans currently live with a long-term or lifelong need for assistance due to a TBI. Technological advancements in ICP monitoring devices such as telemetry features and improved accuracy are assisting medical professionals to noninvasively monitor ICP and help guide optimal treatment.

Market trends:

The market is witnessing a trend of development of non-invasive and minimally invasive ICP monitoring devices. Companies are focusing on developing adhesive patch sensors, wearable devices and smartphone apps that can accurately measure ICP without the need for invasive procedures. Rising preference for ambulatory ICP monitoring devices is another key trend. Ambulatory monitoring enables enhanced monitoring of patients outside of critical care units.

Market Opportunities:

Untapped growth potential in developing countries due to lack of awareness and high device costs offers key opportunities. Increasing application of ICP monitoring devices in neuro-intensive care units and operating rooms also offers lucrative opportunities. The rising demand for ambulatory ICP monitoring devices especially among brain tumor patients also presents a major market opportunity over the forecast period.

Impact of COVID-19 on Intracranial Pressure Monitoring Devices Market

The COVID-19 pandemic has significantly impacted the growth of the intracranial pressure monitoring devices market. During the initial lockdown phase, the market witnessed a sharp decline in demand due to the postponement of elective surgeries and delay in new patient registrations. Hospital resources were diverted to increase COVID-19 treatment capacity and focus on critical cases. However, as the pandemic progresses, the need for monitoring ICP in COVID-19 infected patients presenting with neurological manifestations like seizures, ischemic strokes has increased. With emerging evidence that SARS-CoV-2 virus can cause secondary brain complications due to hypoxemia and coagulopathy, invasive ICP monitoring is being utilized more widely. Market players are also ramping up production capacity to meet the growing demand. Going forward, as the pandemic situation stabilizes, it is expected that the market will return to its normal growth trajectory aided by rise in traumatic brain injuries and investments in improving neurocritical care infrastructure across developing regions.

Geographical Regions with Highest Value Share in Intracranial Pressure Monitoring Devices Market

North America accounts for the largest share of the intracranial pressure monitoring devices market in terms of value. This can be attributed to the high incidence of neurological disorders, developed healthcare infrastructure, availability of advanced treatment options and favorable reimbursement policies in the region. The United States represents the major market within North Americadue to presence of prominent market players, high patient awareness levels regarding ICP management and growing adoption of invasive monitors among providers.

Fastest Growing Regional Market for Intracranial Pressure Monitoring Devices

The Asia Pacific region is poised to be the fastest growing market for intracranial pressure monitoring devices globally during the forecast period. Factors such as rise in traumatic brain injuries from road accidents, increasing medical tourism, improving healthcare expenditures and expansion of private insurance coverage are driving higher adoption. Additionally, growing aged population susceptible to neurodegenerative conditions is propelling the uptake. China and India are anticipated to significant markets within Asia Pacific due large patient pools and health systems prioritizing investments to strengthen neuroscience facilities.